Sustained Results: Trial Data on Diabetes Control The maximum prescribable dosage of semaglutide has increased as additional research is published
Customized Treatment Plan Weight loss is not a one-size-fits-all approach
GLP-1 receptor agonists bind to GLP-1 receptors on pancreatic beta cells, stimulating glucose-dependent insulin secretion whilst simultaneously suppressing glucagon release from alpha cells
When obtaining a prescription, be sure youre working with a trusted, licensed prescriber and pharmacy.
However, oral semaglutide is currently only FDA-approved for diabetes management, not specifically for weight loss like Wegovy injections
For patients who are newer to GLP-1 therapy or who want to start with semaglutide before potentially switching from tirzepatide to semaglutide or vice versa, this provides flexibility